logo
logo
Sign in

Increasing Demand For Automated Immunoassay Analyzers To Increase Efficiency During COVID-19 Diagnosis Is Anticipated To Openup The New Avenue For Chemiluminescence Immunoassay Market

avatar
ashwinicmi
Increasing Demand For Automated Immunoassay Analyzers To Increase Efficiency During COVID-19 Diagnosis Is Anticipated To Openup The New Avenue For Chemiluminescence Immunoassay Market

The Chemiluminescence Immunoassay Market is estimated to be valued at US$ 7.01 Bn in 2023 and is expected to exhibit a CAGR of 8.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Chemiluminescence immunoassay (CLIA) is an immune-analytical technique used for detecting or quantifying the specific antigens or antibodies in a sample. It makes use of a chemical emission of light triggered by a chemical reaction to detect the interaction between an antigen or antibody and its binding partner. CLIA offers high sensitivity and specificity for detecting various proteins, hormones, drugs and infectious agents in serum or plasma. It is widely used for detecting serum markers of cardiac diseases, thyroid disorders and infectious diseases like HIV and hepatitis. Automated chemiluminescence immunoassay analyzers provide standardized, high throughput testing and offer efficient diagnosis of diseases.

Market Dynamics:

The growth of the global chemiluminescence immunoassay market is mainly driven by increasing demand for automated immunoassay analyzers with higher throughput for large volume testing. According to estimates, around 2 million CLIA tests are performed per day globally. This necessitates efficient, automated immunoassay systems to meet the demand of diagnostic laboratories. Growing burden of chronic and infectious diseases globally also supports market growth, as CLIA is widely used for disease screening, diagnosis and management. Furthermore, advancement of CLIA technology with better sensitivity and high throughput automated systems is encouraging its adoption in emerging markets. However, stringent regulatory frameworks for approvals of new CLIA diagnostic kits and analyzer systems can hamper market growth.

Segment Analysis

The chemiluminescence immunoassay market is dominated by the immunoassay analyzers segment. This segment has the largest market share as chemiluminescence immunoassay tests can only be conducted on specialized analyzers designed to detect chemiluminescent signals. Top companies are focusing on developing high throughput, automated, and random-access immunoassay analyzers which can process large numbers of samples quickly while minimizing errors.

PEST Analysis

Political: Regulations regarding clinical trials and approval processes for diagnostic medical devices are becoming more stringent. This increases compliance costs for companies.

Economic: The global economy is recovering post-pandemic which is increasing healthcare spending and demand for advanced diagnostic tests.

Social: Rising prevalence of chronic and infectious diseases is driving awareness and screenings. An aging population also contributes to growth in disease diagnosis.

Technological: Automation, miniaturization of assays and analyzers, and multiplexing capabilities allow testing of multiple analytes from a single patient sample are boosting efficiency and volumes.

Key Takeaways

The Global Chemiluminescence Immunoassay Market Demand is expected to witness high growth, exhibiting CAGR of 8.0% over the forecast period, due to increasing demand for automated, high-throughput, and reliable diagnostic testing solutions.

Regionally, North America captured the largest revenue share in 2023 owing to developed healthcare infrastructure, availability of advanced diagnostic equipment, and large patient pool affected by chronic conditions. Europe was the second largest regional market.

Key players operating in the chemiluminescence immunoassay market are DiaSorin S.p.A., Abbott Laboratories, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers, Beckman Coulter Inc., F. Hoffmann-La Roche AG, Inova Diagnostics, Inc., Maccura Biotechnology Co., Ltd., Tosoh Corporation, and Ortho Clinical Diagnostic.

Read More:

https://www.pressreleasebulletin.com/chemiluminescence-immunoassay-market-trends-and-forecast/

collect
0
avatar
ashwinicmi
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more